KIT and paraganglioma: Firstly, we compared the whole expression profiles in an unsupervised manner, adopting PCA as previously described, putting together SDHB-mutant pheochromocytoma/paraganglioma and our microarray GIST samples (both SDH-deficient and KIT-mutant).